NVS

Novartis AG (NVS)

Last Price$105.7(0.7%)
Market Cap$234.5B
LTM Revenue
$49.3B
YoY Growth
-5.8%
3Y CAGR
-2.0%
5Y CAGR
-0.1%
Stock quality & Intrinsic value
7/10
10.4% undervalued

Novartis AG Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$28.2B
$32.5B
$36.7B
$38.9B
$42.6B
$45.1B
$51.6B
$59.4B
$57.6B
$58.8B
$53.6B
$50.4B
$49.4B
$50.1B
$53.2B
$48.7B
$49.9B
$52.9B
$51.8B
$46.7B
See the NVS
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for NVS
Explore -->

Novartis AG (NVS) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Novartis AG's Revenue?

As of today, Novartis AG's last 12-month Revenue is $49.3B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Novartis AG's Revenue growth rate?

Over the last year, Novartis AG's Revenue growth was (5.8%). The average annual Revenue growth rates for Novartis AG have been (0.4%) over the past three years, (0.1%) over the past five years.

3) Is Novartis AG's Revenue growth rate Good?

Over the last year, Novartis AG's Revenue growth was (5.8%), which is lower than industry growth of 0.1%. It indicates that Novartis AG's Revenue growth is Bad.

4) How does Novartis AG's Revenue growth rate compare to its peers?

Over the last year, Novartis AG's Revenue growth was (5.8%), which is lower than peer median growth of 12.2%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, AZN, BMY, LLY, AMGN, GILD etc.